long-acting beta2-agonist

DRUG2 trials

Sponsors

National Heart, Lung, and Blood Institute (NHLBI), Novartis Pharmaceuticals

Conditions

AsthmaChronic Obstructive Pulmonary Disease (COPD)Lung Diseases

Phase 3

Pediatric Asthma Controller Trial (PACT)

CompletedNCT00272506

National Heart, Lung, and Blood Institute (NHLBI)Asthma, Lung Diseases

Start: 2002-08-31End: 2004-09-30Updated: 2016-07-12

12-week Open-label Evaluation of Efficacy and Safety of Indacaterol

CompletedNCT01232894

Novartis PharmaceuticalsChronic Obstructive Pulmonary Disease (COPD)

Start: 2011-03-31End: 2012-05-31Updated: 2013-11-19